Kalpa Pharmaceuticals has been gaining considerable buzz recently, fueled by a string of successful developments and a impressive expansion in its pipeline . While still a newer company, Kalpa’s focus on niche therapies, particularly in oncology rare diseases , has set it as a likely disruptor in